Adalimumab/etanerceptAutoimmune renal disorders: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1528卷 / 1期

关键词：

D O I：

10.1007/s40278-014-5023-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[1] Adalimumab/etanerceptAutoimmune phenomena in elderly patients: 3 case reports
Reactions Weekly, 2012, 1418 (1) : 6 - 6
[2] Adalimumab/infliximabPsoriatic disorders: 3 case reports
Reactions Weekly, 2014, 1501 (1) : 5 - 5
[3] Adalimumab/etanercept/infliximabNeuromuscular disorders: 3 case reports
Reactions Weekly, 2008, 1224 (1) : 4 - 4
[4] Adalimumab/etanercept/infliximabDemyelinating disorders: 3 case reports
Reactions Weekly, 2009, 1252 (1) : 6 - 6
[5] SunitinibCardiovascular disorders and renal disorders: 3 case reports
Reactions Weekly, 2011, 1339 (1) : 36 - 36
[6] Adalimumab/etanerceptAutoimmune encephalitis and lack of efficacy: case report
Reactions Weekly, 2022, 1896 (1) : 20 - 20
[7] Adalimumab/etanerceptGastrointestinal disorders: 8 case reports
Reactions Weekly, 2017, 1649 (1) : 18 - 18
[8] EtanerceptAutoimmune skin rash: 2 case reports
Reactions Weekly, 1999, 779 (1) : 9 - 9
[9] Adalimumab/etanercept/infliximabSkin disorders: 11 case reports
Reactions Weekly, 2007, 1163 (1) : 5 - 5
[10] Adalimumab/etanercept/infliximabLung disorders: 4 case reports
Reactions Weekly, 2008, 1210 (1) : 6 - 6

← 1 2 3 4 5 →